Compugen Ltd. Corporation

Alexander Diber

Zurit Levine

Sarah Rachel Pollock

Amit Novik

Amir Toporik

Gad S Cojocaru

Dvir Dahary

Michal Ayalon-Soffer

Ronen Shemesh

Osnat Sella-Tavor

Shirley Sameah-Greenwald

Shira Walach

Yossi Cohen

Pinchas Akiva

Rotem Sorek

Guy Kol

Maxim Shklar

Naomi Keren

Sergey Nemzer

Lily Bazak

Michal Avalon-Soffer

Zipi Shaqed

Ariel Farkash

Novel markers for ovarian cancer that are both sensitive and accurate. These markers are overexpressed and/or differentially expressed in ovarian cancer specifically, as opposed to normal ovarian tissue. The measurement of these markers, alone or in combination, in patient samples provides information that the diagnostician can correlate with a probable diagnosis, in ovarian cancer. The markers of the present invention, alone or in combination, show a high degree of differential detection between ovarian cancer and non-cancerous states.

Nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of ovarian cancer

Novel splice variant nucleic acid sequences. The novel splice variants and their nucleic acid sequences according to the present invention may optionally be used for diagnosis of a variant-detectable disease as described herein.

Nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis

Novel markers for cardiac disease that are both sensitive and accurate. These markers are differentially and/or specifically expressed in cardiac tissue, as opposed to other types of tissues, optionally and preferably including muscle tissue. The measurement of these markers, alone or in combination, in patient samples provides information that the diagnostician can correlate with a probable diagnosis of cardiac disease, including pathology and/or damage, including acute and/or chronic damage. The markers of the present invention, alone or in combination, show a high degree of differential detection between cardiac disease states and non-cardiac disease states.

Nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of cardiac disease

Novel markers for lung cancer that are both sensitive and accurate. These markers are overexpressed in lung cancer specifically, as opposed to normal lung tissue. The measurement of these markers, alone or in combination, in patient samples provides information that the diagnostician can correlate with a probable diagnosis of lung cancer. The markers of the present invention, alone or in combination, show a high degree of differential detection between lung cancer and non-cancerous states.

Nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of lung cancer

Novel markers for breast cancer that are both sensitive and accurate. These markers are overexpressed in breast cancer specifically, as opposed to normal breast tissue. The measurement of these markers, alone or in combination, in patient samples provides information that the diagnostician can correlate with a probable diagnosis of breast cancer. The markers of the present invention, alone or in combination, show a high degree of differential detection between breast cancer and non-cancerous states.

Nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of breast cancer

Novel BNP variants. The novel BNP variants according to the present invention may optionally be used for diagnosis of a BNP variant-detectable disease as described herein.

Brain natriuretic peptide spliced variant

Growing community of inventors

Rishon-LeZion, Israel

Alexander Diber